Clinical trial · Interventional
Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas
NCT01903239CI-TRIAL-00020806unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the narrowest excision margin for head and neck Basal Cell Carcinoma (BCC) tumors satisfying the National Comprehensive Cancer Network® (NCCN) low-risk for recurrence clinical and histopathological criteria that gives an acceptable (95%) clinical cure-rate over a 3 year follow-up period. Margins of 1 and 2mm are evaluated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low-Risk BCC Excisional Margins | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Low-Risk BCC Excisional Margins
- description
- This is a study investigating the efficiency of 1-2 mm margins for the excision of low-risk basal cell carcinoma.
- interventionNames
- Procedure: Low-Risk BCC Excisional Margins
Primary outcomes (1)
- measure
- Success rate of narrow (1 and 2mm)margin excision of low-risk facial BCC
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patient has a BCC \<10mm on their cheeks, forehead, scalp \& neck or \<6mm on their central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible, preauricular \& postauricular, temple \& ear * The BCC has well defined borders * The BCC is primary * The Patient is not immunosuppressed * The BCC is not located at a site of prior radiation therapy * The histologic subtype is nodular or superficial * There is no perineural involvement Exclusion Criteria: * Patient has a BCC \>or=10mm on their cheeks, forehead, scalp \& neck or \>or=6mm on their central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible, preauricular \& postauricular, temple \& ear * The BCC has poorly defined borders * The BCC is recurrent * The Patient is immunosuppressed * The BCC is located at a site of prior radiation therapy * The histologic subtype is aggressive * There is perineural involvement
References
Publications (0)
Data not yet available
No reference posted for this study.